← Eichor
Study identifier: NCT05719779 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

Condition: Oral Cancer · Pharynx Cancer · Sleep Apnea  ·  Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

PhaseNA
Planned participants35
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.

This description comes directly from the study's public registry record.

Talk to the study team

Gilles Lavigne, DMD, PhD  ·  514-343-2310  ·  gilles.lavigne@umontreal.ca

Matthieu Schmittbuhl, DDS, PhD  ·  514 890-8000  ·  matthieu.schmittbuhl@umontreal.ca

Always discuss trial participation with your own doctor first.

Locations (1)

CHUMMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05719779